MRK
Merck & Company, Inc. · Healthcare · Drug Manufacturers - General
TECHNeutralZACKSHold
R500#224 today
$144.30
+0.34% today · -3.01% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- MRK +0.34% on the last session vs SPY +0.74%: −0.4 pts of stock-specific move.
- Aftermath, big drop (Sep 30): After its 71 big drops in the past 5 years, MRK typically gained 1.5% over the next month (median) and was higher 58% of the time; half the outcomes fell between -2.3% and +4.8%. An ordinary month: +1.3%. Among S&P 500 stocks after big drops, that ranks #263 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
MRK against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #224 | +0.34% | +0.74% | |
| 1 week | #388 | -3.01% | -0.22% | |
| 1 month | #220 | -4.28% | +0.84% | |
| 3 months | #71 | +12.03% | +3.59% | |
| 6 months | #113 | +20.95% | +17.95% | |
| 1 year | #45 | +65.94% | +16.25% | |
| Overall | #128 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Drug Manufacturers - General
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | 0.11 | #393 | #4 |
| fPE/tPE | 0.13 | #12 | #1 |
| PE/G | 2.64 | #405 | #6 |
| EV/Revenue | 6.05 | #147 | #6 |
| Gross Margin | 0.76 | #54 | #4 |
| Profit Margin | 0.05 | #415 | #8 |
| Revenue Growth | 0.05 | #348 | #7 |